Target intelligence / Profile preview

5-hydroxytryptamine receptor 3A subunit (5-HT3A)

Target
5-HT3A
Molecular classification
Ion channel, Ligand-gated ion channel, Receptor, Cys-loop superfamily, Pentameric ligand-gated ion channel (pLGIC)
01

Overview

The 5-hydroxytryptamine receptor 3A subunit (5-HT3A) is a protein that, together with other 5-HT3 subunits, forms the functional 5-HT3 receptor, a ligand-gated cation-selective ion channel of the Cys-loop superfamily. It uniquely mediates fast excitatory neurotransmission by opening in response to serotonin (5-HT) binding, allowing the rapid influx of sodium, potassium, and to some extent calcium ions through the cell membrane, ultimately leading to neuronal depolarization. The 5-HT3A subunit is essential for receptor function: either as a homopentamer (five 5-HT3A subunits) or as the required component in heteropentameric complexes with other related subunits (5-HT3B, C, D, or E). Pharmacologically, the 5-HT3 receptor is notable as the target of several potent antiemetic drugs (“setrons,” such as ondansetron) used to treat nausea and vomiting, especially in cancer and post-surgical patients. It is uniquely not a G-protein coupled receptor (unlike most serotonin receptor subtypes), but rather directly forms an ion channel. Its function and pharmacology are further influenced by alternative subunit composition, post-translational modification (e.g., glycosylation), and interaction with intracellular proteins. Overall, the 5-HT3A subunit is central both to basic neurotransmission and to drug action in the nervous and gastrointestinal systems.

Other names
5-HT3A5-HT3 receptor A subunitSerotonin receptor 3A subunitHTR3A5-hydroxytryptamine type 3A receptor
02

Mechanism of action

Competitive antagonism at the 5-HT3 (ligand-binding) site; Blockade of serotonin-induced opening of the ion channel, inhibiting depolarization and neuronal firing

03

Biological functions

Signal transductionFast synaptic neurotransmission (excitatory)Cation transport (mediates influx of Na^+, K^+, and Ca^2+)
04

Disease associations

Nausea and vomiting (especially chemotherapy-induced)Irritable bowel syndromeAnxiety disordersAlcohol dependenceSchizophrenia (as a possible modulator)Potential role in other gastrointestinal and psychiatric disorders
05

Safety considerations

Risk of QT interval prolongation and cardiac arrhythmias, especially with certain 5-HT3 antagonistsHeadache, constipation or diarrhea, dizzinessLess commonly, serotonin syndrome when combined with other serotonergic agents
06

Interacting drugs

Ondansetron

5 more in the full profile.

07

Biomarkers

Overexpression or increased activity in gastrointestinal tissue or CNS as a predictor of emetogenic risk (for antiemetic treatment tailoring)Potential pharmacogenetic markers (e.g., HTR3A polymorphisms influencing drug efficacy/side effects)

Beyond the preview

Go deeper on 5-hydroxytryptamine receptor 3A subunit (5-HT3A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5-hydroxytryptamine receptor 3A subunit (5-HT3A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call